6 Stocks Protecting America's Borders and Citizens Three Different Ways - Wealthy Venture Capitalist

6 Stocks Protecting America’s Borders and Citizens Three Different Ways

WINDSOR, ON / ACCESSWIRE / December 11, 2015 / The Wealthy Biotech Trader (or “WBT”), an investment newsletter focused on showing everyday investors new opportunities in rapidly growing, little-known, biotech, pharma and medical device stocks making news and subsequent market moves, would like to announce 6 stocks helping protect America:

2 defense/ homeland security stocks:

PositiveID Corporation (PSID)

American Science & Engineering (ASEI)

2 cyber security stocks:

Zix Corporation (ZIXI)

The KEYW Holding Corporation NASDAQ: KEYW)

2 small weapons manufacturers:

Smith & Wesson Holding Corporation (NASDAQ:SWHC)

Taser International Inc. (NASDAQ:TASR)

The First on our list are two companies making the “picks and shovels” to protect America: Biological threat detection and physical weapon detection:

PositiveID (PSID). PSID is a medical device company developing the Firefly Dx, a handheld device that is essentially a “lab in the hand,” which, when fully developed, could test anyone or anything for contamination from bioagents or other illness ranging from smallpox, Ebola, E.coli, influenza, MRSA, anthrax and others within 20 minutes. Traditionally this testing is much more expensive and take at least 4 hours. This is a product that could be deployed by the U.S. Government to screen refugees for diseases, which are currently a large threat to the country. Firefly Dx was recently a part of the Department of Homeland Security’s SenseNet Phase I program to implement faster, less expensive bio-threat detection systems.

Also applicable to the tumultuous times we live in is another one of PSID’s products (which is fully developed), the M-BAND. PSID’s M-BAND was developed under contract with the U.S. Department of Homeland Security, and is a bio-aerosol monitor, processor and detection module. M-BAND runs autonomously for up to 30 days in areas with large amounts of human traffic such as airports, continuously analyzing air samples  for the detection of bacteria, viruses, and toxins with results in as little as three hours. Results from individual instruments are reported via a secure wireless network in real time to give an accurate and up to date status. This could be deployed by the Department of Homeland Security, The Center for Disease Control and the FBI. PositiveID’s (PSID) M-BAND is exclusively licensed by The Boeing Company (NYSE:BA).

Considering the current state of “near-war” in Syria, Iraq and near the Turkish border; the heightened tensions in Russia, Turkey, France and the U.S.; and recent domestic terror events in the U.S. and corresponding concern regarding security of U.S. borders, it would be smart to assume PSID is in the right place at the right time.

One large order for either product from only one or more federal agencies could send this tiny $0.02 stock soaring.

PSID just announced in a news release they increased their net revenues 260% for the 9 months ending September 30th, 2015–very impressive. The strong earnings release pre-dated the most recent news of acquiring Thermomedics, which is said to be a strategic target to bolster theFirefly Dx brand.Download Kik for PC Learn How to Install Kik Messenger for PC on Windows 7/8.1/10. Kik Online Login is an Instant Messaging App for PC The stock chart looks to be nearing a new support level in the $0.02 range which could set the stage for another run upward towards the 52-week high of $0.05 and beyond.

Next on the list is American Science & Engineering (ASEI). ASEI is the trusted global provider of threat and contraband detection solutions for ports, borders, military, critical infrastructure, law enforcement, and aviation. With over 50 years of experience, AS&E offers proven, advanced X-ray inspection systems to combat terrorism, drug smuggling, illegal immigration, and trade fraud. AS&E systems are designed in a variety of configurations for cargo and vehicle inspection, parcel inspection, and personnel screening. We like to look at stocks at 52 week lows which are simply broken stocks, not broken companies–ASEI appears to be just that. ASEI pays almost a 5% dividend, which should pique some investors’ interest, as well as some analysts pointing to higher earnings estimates for next year–maybe the market has not caught on yet, as it sometimes does for small cap companies.

WBT feels the next 10 years for cyber security could bode well for investors, but there are many frogs to kiss before a handsome stock appears. There will most likely be 1 or 2 small cap companies to make it big out of the field of dreams–investors really just need to place the right bet on the intellectual property/ human capital as that’s who will strike it big.

Our first cyber security company is Zix Corporation (ZIXI). ZIXI is a leader in email data protection. ZixCorp offers industry-leading email encryption, a unique email DLP solution and an innovative email BYOD solution to meet a company’s data protection and compliance needs. ZixCorp is trusted by the nation’s most influential institutions in healthcare, finance and government for easy to use secure email solutions. With the two hallmarks (revenue andEARNINGS) of a premier small cap tech firm, ZIXI looks to be a ticker to watch for the long-term. The recent earnings report from the company in October was impressive to say the least. Investors are encouraged to take a look and do some due diligence on this name.

Second on the cybersecurity watch list is The KEYW Holding Corporation NASDAQ: KEYW). KEYW is a team of cybersecurity experts delivering solutions that enable organizations to defend against and remove cyber threats at machine speeds before they do damage. Hexis’ advanced security solutions use real-time endpoint sensors, network detection, and threat analytics to provide organizations with an intelligent and automated threat detection and response solution. With revenues somewhat stagnant, and selling, general administrative costs soaring, it’s hard to make an investment case with this name. The chart also appears to be echoing the same narrative…Unless something drastic changes here (activist shareholder creating a shakeup, the board shaking up the management team, a key acquisition of a much needed technology to grow the firm), this one should be watch-listed.

Lastly, the most obvious response to fear: weaponry. We split the stock plays in this area into two– deadly weapons (guns) and less lethal weapons (Tasers).

A household name, Smith & Wesson Holding Corporation (NASDAQ:SWHC), just printed a 15-year high on the heels of more gun control talk, which typically provokes pro-gun advocates to hoard weapons. SWHC is a U.S.-based leader in firearm manufacturing and design, delivering a broad portfolio of quality firearms, related products, and training to the global military, law enforcement, and consumer markets. Technically (new chart break-out) and fundamentally (the company just raised 2016 earnings guidance) SWHC looks like a great play to get some exposure to the craziness surrounding America.

On a less lethal note, Taser International Inc. (NASDAQ:TASR) is also making a bullish stock run. TASR was performing stronger in Q3 due to the police shooting controversy sweeping America as they are the makers of one of the most standard-issue “body cameras” worn by police officers. Although TASR is the maker of the famous “stun gun,” the future growth, in WBT’s opinion, lies on the body camera side as more and more governors, mayors and police chiefs are calling for them. The future could also be driven by acquisition of other companies in synergistic business to TASR–the time to do so is when your stock is strong and TASR’s stock has been on a tear.

To receive text Message alerts when new articles are released click here: http://clk2.it/k7oF5z.

Follow us on Twitter: @Wealthy_VC

Like us on Facebook: www.facebook.com/WealthyVC

The Wealthy Biotech Trader is always researching new trade ideas which have the makings for large market moves. Traders are urged to follow our parent outlet, The Wealthy Venture Capitalist on social media (see below) to stay apprised. We are an anti-email media outlet, and as such will only be releasing our reports/ updates/ news through Twitter and Facebook as well as newswire.

GET BREAKING NEWS FROM US:

To receive text Message alerts when new articles are released click here: http://clk2.it/k7oF5z.

Follow us on Twitter: @Wealthy_VC

Like us on Facebook: www.facebook.com/WealthyVC

Email: Info@WealthyVentureCapitalist.com

This report/release/profile is a commercial advertisement and is for general information purposes only. We are engaged in the business of marketing and advertising companies for monetary compensation unless otherwise stated below. The Wealthy Biotech Trader and its employees are not a Registered Investment Advisors, Broker Dealers or a member of any association for other research providers in any jurisdiction whatsoever and we are not qualified to give financial advice. The information contained herein is based on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Sometimes human error can attribute to honest mistakes in reporting on issues regarding public companies and overall capital markets, and as such we are not responsible for the complete accuracy in these reports as the reader is required to verify all statements to ensure they are completely accurate. The Wealthy Biotech Trader encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled through their website, news releases, and corporate filings, or is available from public sources and The Wealthy Biotech Trader makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled companies. The Private Securities Litigation Reform Act of 1995 provides investors a “safe harbor” in regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical fact may be “forward looking statements”. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as “projects,” “foresee,” “expects” “will,” “anticipates,” “estimates,” “believes,” “understands,” or that by statements indicating certain actions “may,” “could,” or “might” occur. Understand there is no guarantee past performance will be indicative of future results. Past Performance is based on the security’s previous day closing price and the high of day price during our promotional coverage.

The Wealthy Biotech Trader’s parent company has been and will be compensated roughly $25,000 per month by PositiveID. The Wealthy Biotech Trader’s controlling parent company has also been compensated $125,000 by PositiveID in the form of 2 convertible notes and readers should understand that they will convert this note into common shares sell them into the market as soon as the statutory 144 hold period has lapsed.

Readers must visit our website at www.wealthyventurecapitalist.com in order to view our entire disclaimer which covers most of the risks, biases and liability releases to have a full understanding after reading this art.

SOURCE: The Wealthy Biotech Trader

Related News

Leave a Reply

Your email address will not be published. Required fields are marked *

pour la musculation tamoxifen buylivraison anonyme, prix favorable As a rule, the infection occurs during penetrative sexual intercourse buy metronidazole no prescription moist environment and can remain viable. cialis 20mg rezeptfreider Wirkstoff des Arzneimittels wird nicht verlassen, Zweifel an der Wirksamkeit der Pillen ein bewährtes Medikament zur Behandlung von BPH in einer Dosierung von 10 mg, die Möglichkeit gibt, ein neues Potential des Penis, um zu versuchen buy Retin AThis drug will no doubt help to solve the problem with acne in young people from 16 years, thanks to the active ingredient of this cream you will experience relief, people will stop laughing at you Diagnosticare la causa della disfunzione erettilecomprar cilaiscosì spesso il trattamento può comportare molteplici tecniche. Comprar cialis en línea

Wealthy Venture Capitalist